Fitness & Wellness

FDA Clears Intraoral Biosensor for Sleep Apnea Therapy and Monitoring

28 sec read52 views0 listens

The FDA has granted clearance for a new prescription device, the iNOS intraoral biosensor, designed to treat sleep apnea and reduce snoring. This development is significant because it integrates continuous blood oxygen monitoring directly into an oral appliance, allowing for more precise assessment of therapy effectiveness and potentially improving patient outcomes related to sleep-disordered breathing. A soft launch is planned for October, with broader availability expected in early 2027.

Read the full article at Sleep Review

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

You Might Like

AI & Machine Learning1 day ago26 sec read

Architecting a Resilient DevSecOps Pipeline for Enterprise AI Agents

A new four-stage DevSecOps pipeline architecture is proposed to secure enterprise AI agent applications against emerging vulnerabilities. This pipeline integrates automated secret detection, AI-driven code and prompt analysis, and software compositio...

Ali Nemati

Cybersecurity3 days ago31 sec read

Cyberattacks on Oil Tankers Put Maritime Critical Infrastructure at Risk

Recent cyberattacks targeting two energy tankers en route to the U.S. highlight vulnerabilities in maritime critical infrastructure. These incidents, potentially linked to Iranian actors, demonstrate that connected ship systems – including navigation...

Ali Nemati

AI & Machine LearningSep 1327 sec read

Learn Eval Ownership by Building a Tiny Lab Witness

A case study explores building a name-normalization lab using a local Python script and a remote AI model without compromising sensitive data. The goal was to send only constrained requests to the remote service and maintain a local 'witness' file wi...

Ali Nemati